Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
EDGEWELL PERSONAL CARE Co
Report date December 31, 2021 · Filed January 04, 2022
Section 16 reporting ended · disclosed 2022-01-04. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock Equivalent 11/14/2019SEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2021-12-31 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2021-12-31 · Other · Disposed 1,908 · Balance 0 F1: Unvested award forfeited upon Ms. Iasenza's departure from the Company on December 31, 2021. |
| Restricted Stock Equivalent 4/1/2020SEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2021-12-31 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2021-12-31 · Other · Disposed 8,018 · Balance 0 F1: Unvested award forfeited upon Ms. Iasenza's departure from the Company on December 31, 2021. |
| Restricted Stock Equivalent 11/13/2020SEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2021-12-31 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2021-12-31 · Other · Disposed 4,524 · Balance 0 F1: Unvested award forfeited upon Ms. Iasenza's departure from the Company on December 31, 2021. |
| Restricted Stock Equivalent 11/12/2021SEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2021-12-31 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2021-12-31 · Other · Disposed 4,505 · Balance 0 F1: Unvested award forfeited upon Ms. Iasenza's departure from the Company on December 31, 2021. |
| Performance Stock Equivalent 11-14-2019SEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2021-12-31 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2021-12-31 · Other · Disposed 19,084 · Balance 0 F1: Unvested award forfeited upon Ms. Iasenza's departure from the Company on December 31, 2021. |
| Performance Stock Equivalent 4-1-2020SEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2021-12-31 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2021-12-31 · Other · Disposed 24,056 · Balance 0 F1: Unvested award forfeited upon Ms. Iasenza's departure from the Company on December 31, 2021. |
| Performance Stock Equivalent 11-13-2020SEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2021-12-31 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2021-12-31 · Other · Disposed 10,179 · Balance 0 F1: Unvested award forfeited upon Ms. Iasenza's departure from the Company on December 31, 2021. |
| Performance Stock Equivalent 11-12-2021SEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2021-12-31 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2021-12-31 · Other · Disposed 15,016 · Balance 0 F1: Unvested award forfeited upon Ms. Iasenza's departure from the Company on December 31, 2021. |
| Non-Qualified Stock Options 11-14-2019SEC Table II · derivative / convertible security · Conversion / exercise price $31.44 | Direct | 8,575 |
Reported balance
After 2021-12-31 transaction · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · 2021-12-31 · Other · Disposed 4,287 · Balance 8,575 F2: These unvested options are forfeited upon Ms. Iasenza's departure from the Company. She will have 90 days from her departure date to exercise the options that were vested prior to her departure. |
| Non-Qualified Stock Options 11-15-2018SEC Table II · derivative / convertible security · Conversion / exercise price $42.71 | Direct | 7,711 |
Reported balance
After 2021-12-31 transaction · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · 2021-12-31 · Other · Disposed 0 · Balance 7,711 F3: These options were vested prior to Ms. Iasenza's departure from the Company. She has 90 days from her departure date to exercise them. |
| Non-Qualified Stock Options 11-13-2020SEC Table II · derivative / convertible security · Conversion / exercise price $38.91 | Direct | 3,370 |
Reported balance
After 2021-12-31 transaction · row 12
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 12 · 2021-12-31 · Other · Disposed 6,740 · Balance 3,370 F2: These unvested options are forfeited upon Ms. Iasenza's departure from the Company. She will have 90 days from her departure date to exercise the options that were vested prior to her departure. |
| Non-Qualified Stock Options 11-13-2020SEC Table II · derivative / convertible security · Conversion / exercise price $35.37 | Direct | 1,611 |
Reported balance
After 2021-12-31 transaction · row 13
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 13 · 2021-12-31 · Other · Disposed 3,220 · Balance 1,611 F2: These unvested options are forfeited upon Ms. Iasenza's departure from the Company. She will have 90 days from her departure date to exercise the options that were vested prior to her departure. |
| Non-Qualified Stock Options 11-12-2021SEC Table II · derivative / convertible security · Conversion / exercise price $43.29 | Direct | 0 |
Reported balance
After 2021-12-31 transaction · row 14
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 14 · 2021-12-31 · Other · Disposed 8,899 · Balance 0 F1: Unvested award forfeited upon Ms. Iasenza's departure from the Company on December 31, 2021. |
| Common StockSEC Table I · non-derivative | Direct | 36,467 |
Reported balance
Holding disclosure · report date 2021-12-31 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 36,467 |
Filing footnotes · ownership attribution and instrument terms
F1: Unvested award forfeited upon Ms. Iasenza's departure from the Company on December 31, 2021.
F2: These unvested options are forfeited upon Ms. Iasenza's departure from the Company. She will have 90 days from her departure date to exercise the options that were vested prior to her departure.
F3: These options were vested prior to Ms. Iasenza's departure from the Company. She has 90 days from her departure date to exercise them.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 14, 2019 Filed Nov 18, 2019 18:31 UTC | EDGEWELL PERSONAL CARE Co EPC · Entity 4787 | GrantRestricted Stock Equivalents (RSE) 11/14/2019 · Derivative | 5,726 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-056883 · doc4.xml · derivative · entry 2 IASENZA MARISA · CIK 0001741891 · Chief Legal Ofcr & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,726 Underlying: Common Stock · 5,726 shares Expires not disclosed F2 · derivative.exercise_date: One-third of the RSEs will vest and convert into shares of Edgewell common stock on each of 11/14/2020, 11/14/2021 and 11/14/2022 if the Reporting Person is employed on said dates, or all or a portion may vest upon death, disability, change in control or certain termination events. F2 · derivative.expiration_date: One-third of the RSEs will vest and convert into shares of Edgewell common stock on each of 11/14/2020, 11/14/2021 and 11/14/2022 if the Reporting Person is employed on said dates, or all or a portion may vest upon death, disability, change in control or certain termination events. Read SEC document |
| November 14, 2019 Filed Nov 18, 2019 18:31 UTC | EDGEWELL PERSONAL CARE Co EPC · Entity 4787 | GrantNon-Qualified Stock Options 11/14/2019 · Derivative | 12,862 | $0.00 Strike: $31.44 | $0.00 |
DisclosureSEC source: 0001209191-19-056883 · doc4.xml · derivative · entry 1 IASENZA MARISA · CIK 0001741891 · Chief Legal Ofcr & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,862 Underlying: Common Stock · 12,862 shares Expires 2029-11-14 F1 · derivative.exercise_date: One-third of the Options will become exercisable on each of 11/14/2020, 11/14/2021 and 11/14/2022, as long as the Reporting Person is employed on said dates, or all or a portion may vest upon death, disability, change in control or certain termination events. Read SEC document |
| July 02, 2019 Filed Jul 3, 2019 17:46 UTC | EDGEWELL PERSONAL CARE Co EPC · Entity 4787 | Exercise / conversionRestricted Stock Equivalents (RSE) 7/2/2018 · Derivative | 4,162 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-040814 · doc4.xml · derivative · entry 3 IASENZA MARISA · CIK 0001741891 · Chief Legal Ofcr & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,162 Underlying: Common Stock · 4,162 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Restricted stock equivalents vested and converted into shares of EPC common stock on 7/2/2019. F2 · derivative.expiration_date: Restricted stock equivalents vested and converted into shares of EPC common stock on 7/2/2019. Read SEC document |
| July 02, 2019 Filed Jul 3, 2019 17:46 UTC | EDGEWELL PERSONAL CARE Co EPC · Entity 4787 | Tax withholdingCommon Stock | 1,930 | $27.55 | $53,171.50 |
DisclosureSEC source: 0001209191-19-040814 · doc4.xml · nonDerivative · entry 2 IASENZA MARISA · CIK 0001741891 · Chief Legal Ofcr & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,232 F1 · shares: Shares withheld as payment of a tax liability on vesting of restricted stock equivalents. Read SEC document |
| July 02, 2019 Filed Jul 3, 2019 17:46 UTC | EDGEWELL PERSONAL CARE Co EPC · Entity 4787 | Exercise / conversionCommon Stock | 4,162 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-040814 · doc4.xml · nonDerivative · entry 1 IASENZA MARISA · CIK 0001741891 · Chief Legal Ofcr & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,162 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 23, 2019 Filed May 23, 2019 17:39 UTC | EDGEWELL PERSONAL CARE Co EPC · Entity 4787 | PurchaseCommon Stock | 2,800 | $31.22 | $87,412.64 |
DisclosureSEC source: 0001209191-19-032225 · doc4.xml · nonDerivative · entry 1 IASENZA MARISA · CIK 0001741891 · Chief Legal Ofcr & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Read SEC document |
| May 17, 2019 Filed May 20, 2019 14:48 UTC | EDGEWELL PERSONAL CARE Co EPC · Entity 4787 | PurchaseCommon Stock | 2,200 | $32.78 | $72,116.00 |
DisclosureSEC source: 0001209191-19-031246 · doc4.xml · nonDerivative · entry 1 IASENZA MARISA · CIK 0001741891 · Chief Legal Ofcr & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,200 Read SEC document |
| November 15, 2018 Filed Nov 19, 2018 18:54 UTC | EDGEWELL PERSONAL CARE Co EPC · Entity 4787 | GrantPerformance Stock Equivalents (PSE) 11/15/2018 · Derivative | 49,169 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-059118 · doc4.xml · derivative · entry 3 IASENZA MARISA · CIK 0001741891 · Chief Legal Ofcr & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,169 Underlying: Common Stock · 49,169 shares Expires not disclosed F3 · derivative.exercise_date: The PSEs will vest and convert into shares of Edgewell common stock on the date that Edgewell releases its earnings for the fiscal year ending September 30, 2021 if specified performance criteria are met, subject to the exercise of negative discretion by the Compensation Committee of Edgewell's Board of Directors. The performance goals for the PSEs are the adjusted earnings per share of the Company for its 2021 fiscal year, the adjusted cumulative free cash flow of the Company for its 2021 fiscal year as a percentage of adjusted net sales of the Company for fiscal year 2019 through fiscal year 2021, and the achievement of targeted Project Fuel savings for the period ended September 30, 2021. The percentage of the PSEs vesting will range from 0% to 100% based on performance. F3 · derivative.expiration_date: The PSEs will vest and convert into shares of Edgewell common stock on the date that Edgewell releases its earnings for the fiscal year ending September 30, 2021 if specified performance criteria are met, subject to the exercise of negative discretion by the Compensation Committee of Edgewell's Board of Directors. The performance goals for the PSEs are the adjusted earnings per share of the Company for its 2021 fiscal year, the adjusted cumulative free cash flow of the Company for its 2021 fiscal year as a percentage of adjusted net sales of the Company for fiscal year 2019 through fiscal year 2021, and the achievement of targeted Project Fuel savings for the period ended September 30, 2021. The percentage of the PSEs vesting will range from 0% to 100% based on performance. Read SEC document |
| November 15, 2018 Filed Nov 19, 2018 18:54 UTC | EDGEWELL PERSONAL CARE Co EPC · Entity 4787 | GrantRestricted Stock Equivalents (RSE) 11/15/2018 · Derivative | 3,513 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-059118 · doc4.xml · derivative · entry 2 IASENZA MARISA · CIK 0001741891 · Chief Legal Ofcr & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,513 Underlying: Common Stock · 3,513 shares Expires not disclosed F2 · derivative.exercise_date: One-third of the RSEs will vest and convert into shares of Edgewell common stock on each of 11/15/2019, 11/15/2020 and 11/15/2021 if the Reporting Person is employed on said dates, or all or a portion may vest upon death, disability, change in control or certain termination events. F2 · derivative.expiration_date: One-third of the RSEs will vest and convert into shares of Edgewell common stock on each of 11/15/2019, 11/15/2020 and 11/15/2021 if the Reporting Person is employed on said dates, or all or a portion may vest upon death, disability, change in control or certain termination events. Read SEC document |
| November 15, 2018 Filed Nov 19, 2018 18:54 UTC | EDGEWELL PERSONAL CARE Co EPC · Entity 4787 | GrantNon-Qualified Stock Options 11/15/2018 · Derivative | 7,711 | $0.00 Strike: $42.71 | $0.00 |
DisclosureSEC source: 0001209191-18-059118 · doc4.xml · derivative · entry 1 IASENZA MARISA · CIK 0001741891 · Chief Legal Ofcr & Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,711 Underlying: Common Stock · 7,711 shares Expires 2028-11-15 F1 · derivative.exercise_date: One-third of the Options will become exercisable on each of 11/15/2019, 11/15/2020 and 11/15/2021, as long as the Reporting Person is employed on said dates, or all or a portion may vest upon death, disability, change in control or certain termination events. Read SEC document |
| July 02, 2018 Filed Jul 2, 2018 14:33 UTC | EDGEWELL PERSONAL CARE Co EPC · Entity 4787 | GrantRestricted Stock Equivalents (RSE) 7/2/2018 · Derivative | 8,324 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-040155 · doc4.xml · derivative · entry 1 IASENZA MARISA · CIK 0001741891 · Chief Legal Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,324 Underlying: Common Stock · 8,324 shares Expires not disclosed F1 · derivative.exercise_date: One-half of the RSEs will vest and convert into shares of Edgewell common stock on each of 7/2/2019 and 7/2/2020 if the Reporting Person is employed on said dates, or all or a portion may vest upon death, disability, change in control or certain termination events. F1 · derivative.expiration_date: One-half of the RSEs will vest and convert into shares of Edgewell common stock on each of 7/2/2019 and 7/2/2020 if the Reporting Person is employed on said dates, or all or a portion may vest upon death, disability, change in control or certain termination events. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.